NuCana Appoints Ian Webster as Chief Financial Officer
Stocks in this Quantisnow insightHealth Care
Historical context for NCNA
Across the 5 sessions after earlier NCNA headlines, the stock closed higher 2 times and lower 2 times, with a median move of 3.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | NCNA | SPY |
|---|---|---|---|
| May 15, 2026 | NuCana Reports First Quarter 2026 Financial Results and Provides Business Update | +10.1% | -1.2% |
| Mar 20, 2026 | NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update | -3.5% | -1.7% |
| Jan 6, 2026 | NuCana Appoints Theresa Bruce as Chief Operating Officer | +0.0% | +0.6% |
| Nov 14, 2025 | NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update | -2.3% | -0.0% |
| Nov 5, 2025 | NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China | +4.7% | +0.3% |
Quantisnow market dataNASDAQ
NCNA
NuCana plc
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2017
Get push alerts for NCNA
Full NCNA profile on Quantisnow Follow NCNA and get a push notification the moment its next story breaks.